Pfizer and AstraZeneca have set their sights on France with major investments totalling nearly 1bn (USD) ahead of the country’s annual ‘Choose France’ business summit.

Catch up on the top stories to come from the pharma industry over April, including new collaborations set to improve treatments for patients, the latest approvals and more.

The pharma industry’s ability to recoup costs on their drug development pipeline was in trouble, been is the downward spiral coming to an end? Read more.

The orphan drug market has seen robust growth over the past decade, but may face challenges in maintaining its trajectory due to evolving investor and payer preferences.

Catch up on March’s top pharma news, including companies slashing inhaler costs and new hope for the UK life sciences sector.

Join us for the next chapter of GOLD as we launch on our new home here on the EMJ website, providing you with a one-stop-shop for all your healthcare content needs.

GOLD looks back on some of the top pharma news stories from the past month, including new approvals, the latest appointments and departures in the industry and more.

Take a look at some of the top pharma news stories of the past month including the latest investments, emerging technologies, new facilities and more.